209 related articles for article (PubMed ID: 27438606)
1. A Simple Scoring System Predicting the Survival Time of Patients with Bone Metastases after RT.
Zhang WY; Li HF; Su M; Lin RF; Chen XX; Zhang P; Zou CL
PLoS One; 2016; 11(7):e0159506. PubMed ID: 27438606
[TBL] [Abstract][Full Text] [Related]
2. An easy tool to predict survival in patients receiving radiation therapy for painful bone metastases.
Westhoff PG; de Graeff A; Monninkhof EM; Bollen L; Dijkstra SP; van der Steen-Banasik EM; van Vulpen M; Leer JW; Marijnen CA; van der Linden YM;
Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):739-47. PubMed ID: 25260489
[TBL] [Abstract][Full Text] [Related]
3. Gamma Knife surgery for brain metastases from colorectal cancer. Clinical article.
Matsunaga S; Shuto T; Kawahara N; Suenaga J; Inomori S; Fujino H
J Neurosurg; 2011 Mar; 114(3):782-9. PubMed ID: 20950083
[TBL] [Abstract][Full Text] [Related]
4. Predicting the survival of patients with bone metastases treated with radiation therapy: a validation study of the Katagiri scoring system.
Kubota H; Soejima T; Sulaiman NS; Sekii S; Matsumoto Y; Ota Y; Tsujino K; Fujita I; Fujimoto T; Morishita M; Ikegaki J; Matsumoto K; Sasaki R
Radiat Oncol; 2019 Jan; 14(1):13. PubMed ID: 30658673
[TBL] [Abstract][Full Text] [Related]
5. Prognostic factors for survival in patients treated with stereotactic radiosurgery for recurrent brain metastases after prior whole brain radiotherapy.
Caballero JA; Sneed PK; Lamborn KR; Ma L; Denduluri S; Nakamura JL; Barani IJ; McDermott MW
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):303-9. PubMed ID: 22079723
[TBL] [Abstract][Full Text] [Related]
6. Brain metastases from esophageal carcinoma: natural history, prognostic factors, and outcome.
Ogawa K; Toita T; Sueyama H; Fuwa N; Kakinohana Y; Kamata M; Adachi G; Saito A; Yoshii Y; Murayama S
Cancer; 2002 Feb; 94(3):759-64. PubMed ID: 11857310
[TBL] [Abstract][Full Text] [Related]
7. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
Cai Y; Wang WL; Xu B; Zhu GY; Zhang SW
Ai Zheng; 2006 Nov; 25(11):1419-22. PubMed ID: 17094913
[TBL] [Abstract][Full Text] [Related]
8. Risk factors affecting survival after brain metastases from non-small cell lung carcinoma: a follow-up study of 70 patients.
Abrahams JM; Torchia M; Putt M; Kaiser LR; Judy KD
J Neurosurg; 2001 Oct; 95(4):595-600. PubMed ID: 11596953
[TBL] [Abstract][Full Text] [Related]
9. Recursive partitioning analysis (RPA) class does not predict survival in patients with four or more brain metastases.
Nieder C; Andratschke N; Grosu AL; Molls M
Strahlenther Onkol; 2003 Jan; 179(1):16-20. PubMed ID: 12540980
[TBL] [Abstract][Full Text] [Related]
10. Prognostic factors in patients with symptomatic spinal metastases and normal neurological function.
Switlyk MD; Kongsgaard U; Skjeldal S; Hald JK; Hole KH; Knutstad K; Zaikova O
Clin Oncol (R Coll Radiol); 2015 Apr; 27(4):213-21. PubMed ID: 25624156
[TBL] [Abstract][Full Text] [Related]
11. [Prognostic factors for long-term outcome of hepatic resection for colorectal liver metastases].
Aldrighetti L; Castoldi R; Di Palo S; Arru M; Stella M; Orsenigo E; Gavazzi F; Ferla G; Di Carlo V; Staudacher C
Chir Ital; 2005; 57(5):555-70. PubMed ID: 16241086
[TBL] [Abstract][Full Text] [Related]
12. Prognostic factors and a new scoring system for survival of patients irradiated for bone metastases.
Rades D; Haus R; Schild SE; Janssen S
BMC Cancer; 2019 Nov; 19(1):1156. PubMed ID: 31779595
[TBL] [Abstract][Full Text] [Related]
13. The effect of distant metastases sites on survival in de novo stage-IV breast cancer: A SEER database analysis.
Wu SG; Li H; Tang LY; Sun JY; Zhang WW; Li FY; Chen YX; He ZY
Tumour Biol; 2017 Jun; 39(6):1010428317705082. PubMed ID: 28653887
[TBL] [Abstract][Full Text] [Related]
14. [Clinical features and prognostic factors of brain metastasis from colorectal cancer].
Sun Z; Sun Y; Tan L; He J; Li X; She C; Li W
Zhonghua Zhong Liu Za Zhi; 2016 Jan; 38(1):63-8. PubMed ID: 26796809
[TBL] [Abstract][Full Text] [Related]
15. Impact of triple-negative phenotype on prognosis of patients with breast cancer brain metastases.
Xu Z; Schlesinger D; Toulmin S; Rich T; Sheehan J
Int J Radiat Oncol Biol Phys; 2012 Nov; 84(3):612-8. PubMed ID: 22436795
[TBL] [Abstract][Full Text] [Related]
16. Comparison of short-course versus long-course whole-brain radiotherapy in the treatment of brain metastases.
Rades D; Bohlen G; Dunst J; Lohynska R; Veninga T; Stalpers L; Schild SE; Dahm-Daphi J
Strahlenther Onkol; 2008 Jan; 184(1):30-5. PubMed ID: 18188520
[TBL] [Abstract][Full Text] [Related]
17. Bone density as a marker for local response to radiotherapy of spinal bone metastases in women with breast cancer: a retrospective analysis.
Foerster R; Eisele C; Bruckner T; Bostel T; Schlampp I; Wolf R; Debus J; Rief H
Radiat Oncol; 2015 Mar; 10():62. PubMed ID: 25884703
[TBL] [Abstract][Full Text] [Related]
18. Institutional, retrospective analysis of 777 patients with brain metastases: treatment outcomes and diagnosis-specific prognostic factors.
Antoni D; Clavier JB; Pop M; Schumacher C; Lefebvre F; Noël G
Int J Radiat Oncol Biol Phys; 2013 Jul; 86(4):630-7. PubMed ID: 23582409
[TBL] [Abstract][Full Text] [Related]
19. Survival analysis of 254 patients after manifestation of spinal metastases: evaluation of seven preoperative scoring systems.
Wibmer C; Leithner A; Hofmann G; Clar H; Kapitan M; Berghold A; Windhager R
Spine (Phila Pa 1976); 2011 Nov; 36(23):1977-86. PubMed ID: 21304424
[TBL] [Abstract][Full Text] [Related]
20. A new scoring system to predicting the survival of patients treated with whole-brain radiotherapy for brain metastases.
Rades D; Dunst J; Schild SE
Strahlenther Onkol; 2008 May; 184(5):251-5. PubMed ID: 18427755
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
